← Eichor
Study identifier: NCT05991388 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Condition: B-cell Non Hodgkin Lymphoma  ·  Sponsor: University of Birmingham

PhasePhase 2/Phase 3
Planned participants210
Who can joinAll sexes, N/A to 25 Years
Healthy volunteersNo

About this study

The Glo-BNHL trial is trying to find better medicines for children and young people with B-cell non-Hodgkin Lymphoma (B-NHL) that does not go away (refractory B-NHL) or does but comes back again (relapsed B-NHL). B-NHL is a type of cancer that develops inside or outside of lymph nodes (glands) and organs such as the liver or spleen. Examples of B-NHL are Burkitt Lymphoma and Diffuse Large B Cell Lymphoma, which may be other names used to describe this type of cancer. It is very difficult to cure relapsed or refractory B-NHL. The medicines used now are very powerful with many side effects and only cure around 30 in every 100 children treated. It is very important that investigators quickly find better medicines for these children and young people. The Glo-BNHL trial will include three groups of children and young people, each given a new medicine (either alone or with chemotherapy). The investigators are looking to make sure the new medicines are safe and that they work to treat the cancer. If the medicine in one group does not work for a child in the trial, then they may be able to join a different group to have another new medicine. Experts from around the world will carefully pick the medicines most likely to be helpful to be part of the trial. If one of the new medicines seems not to be working as well as hoped then the investigators will take it out of the trial as soon as possible. This will let other new medicines be added to the trial and tested. If a medicine does s…

This description comes directly from the study's public registry record.

Talk to the study team

Joseph Rogers  ·  +44 (0)121 414 8040  ·  glo-BNHL@trials.bham.ac.uk

Sarah Johnson  ·  +44 (0)121 414 8040  ·  glo-BNHL@trials.bham.ac.uk

Always discuss trial participation with your own doctor first.

Locations (11)

The Children's Hospital at WestmeadSydney, New South Wales, AustraliaNot Yet Recruiting
Queensland Children's HospitalBrisbane, Queensland, AustraliaNot Yet Recruiting
Perth Children's HospitalPerth, Washington, AustraliaRecruiting
St. Anna Children's HospitalVienna, AustriaRecruiting
UZ LeuvenLeuven, BelgiumNot Yet Recruiting
Princess Máxima Centre for Pediatric OncologyUtrecht, NetherlandsRecruiting
Starship Children's HospitalAuckland, New ZealandNot Yet Recruiting
Sahlgrenska University HospitalGothenburg, SwedenNot Yet Recruiting
Birmingham Children's HospitalBirmingham, United KingdomRecruiting
Bristol Royal Hospital for ChildrenBristol, United KingdomRecruiting
Royal Manchester Children's HospitalManchester, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05991388